Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16228
Title: A systematic review of ileal conduit and neobladder outcomes in primary bladder cancer
Austin Authors: Crozier, Jack;Hennessey, Derek;Sengupta, Shomik ;Bolton, Damien M ;Lawrentschuk, Nathan
Affiliation: Austin Health, Heidelberg, Victoria, Australia
Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Issue Date: Oct-2016
metadata.dc.date: 2016-06-29
Publication information: Urology 2016; 96: 74-79
Abstract: Treatment for muscle invasive bladder cancer with curative intent includes radical cystectomy and urinary diversion. Using PRISMA guidelines, we conducted a systematic review assessing differences in patient selection, operative parameters, complications, and quality of life between ileal conduit and neobladder cohorts. Ileal conduit cohorts have more advanced age and disease, more comorbidities and complications, and poorer quality of life. Ileal conduit surgery is associated with adverse patient selection that inhibits reasonable comparison of outcomes with neobladder cohorts. Despite this, we observe longer operative times and hospital stays in neobladder cohorts, perhaps reflecting greater technical difficulty and the need for postoperative bladder training.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16228
DOI: 10.1016/j.urology.2016.06.034
ORCID: 0000-0002-5145-6783
0000-0001-8553-5618
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/27374734
Type: Journal Article
Type of Clinical Study or Trial: Reviews/Systematic Reviews
Appears in Collections:Journal articles

Show full item record

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.